S

hortly before his company won the right last week to sell a new drug for severe eczema, Dr. Len Schleifer made a brash promise.

He vowed to price the medicine “responsibly” and avoid the anger that high drug prices have stirred. “You’ll get to judge me and see how we do,” he told me.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • My allergies and eczema are bad, and only steroids have ever really helped me. Then I tried foderma serum randomly and I’m so glad that I did! He helps reduce my rashes and makes the itching stop!

  • It is surprising how gut issues can result from accumulation of toxins and heavy metals, and lead to allergies and sensitivities that can fuel eczema and other skin conditions. It might be far less expensive to diagnose and address such root causes of skin problems.

  • You can only afford to buy these medications if you have insurance. Please tell me how any middle class wage earner that makes less than 100,000 a year can afford half of their earning to go directly to one medication? Lol
    Pharmaceutacal companies are reciculous.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy